Daptomycin and Respiratory disorder - a phase IV clinical study of FDA data

Summary:

Respiratory disorder is reported as a side effect among people who take Daptomycin (daptomycin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Pantoprazole, and have Dry eyes.

The phase IV clinical study analyzes which people have Respiratory disorder when taking Daptomycin. It is created by eHealthMe based on reports of 7,865 people who have side effects when taking Daptomycin from the FDA, and is updated regularly.

What is Daptomycin?

Daptomycin has active ingredients of daptomycin. eHealthMe is studying from 7,879 Daptomycin users. Check the latest studies of Daptomycin.

What is Respiratory disorder?

Respiratory disorder (respiratory disease) is found to be associated with 1,541 drugs and 1,583 conditions by eHealthMe. Check the latest studies of Respiratory disorder.

On Jul, 14, 2026

7,865 people reported to have side effects when taking Daptomycin.
Among them, 12 people (0.15%) have Respiratory disorder.

Could Daptomycin cause Respiratory disorder?

Among these 12 people:

How long have people been on Daptomycin when they have Respiratory disorder? *

What is the gender of people who have Respiratory disorder when taking Daptomycin? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Respiratory disorder when taking Daptomycin? *

What are other drugs people take besides Daptomycin? *

What are other side effects people have besides Respiratory disorder? *

Eosinophilic Pneumonia (eosinophil accumulates in the lung): 3 people, 25.00%
Thrombocytopenia (decrease of platelets in blood): 3 people, 25.00%
Fever: 3 people, 25.00%
Pneumonia: 3 people, 25.00%
Drug Ineffective: 3 people, 25.00%
Lip Dry: 2 people, 16.67%
Depression: 2 people, 16.67%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 2 people, 16.67%
Nail Disorder (disease of nail): 2 people, 16.67%
Marrow Hyperplasia (increased bone marrow): 2 people, 16.67%

What are the existing conditions these people have? *

Thrombocytopenia (decrease of platelets in blood): 2 people, 16.67%
Itching: 2 people, 16.67%
Dry Eyes (lack of adequate tears): 2 people, 16.67%
Streptococcal Infection: 1 person, 8.33%
Stenotrophomonas Infection: 1 person, 8.33%
Staphylococcal Infection (an infection with staphylococcus bacteria): 1 person, 8.33%
Pharyngeal Disorder: 1 person, 8.33%
Osteomyelitis (infection of bone): 1 person, 8.33%
Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 1 person, 8.33%
Fungal Infection: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Daptomycin and have Respiratory disorder?

- Check whether Respiratory disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Daptomycin:

Daptomycin (7,879 reports)

Browse all side effects of Daptomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Respiratory disorder:

Respiratory disorder (1,541 drugs)

Browse all the conditions that are associated with Respiratory disorder:

Respiratory disorder (1,583 conditions)

Related publications that referenced our studies

Saliho?lu M, Turhan V, ?nem Y, Ulcay A, Uzun G, Ay H, "Sudden hearing loss in a patient receiving piperacillin/tazobactam and daptomycin for diabetic foot infection", Scandinavian journal of infectious diseases, 2013 Mar .
Saliho?lu M, Turhan V, ?nem Y, Ulcay A, Uzun G, Ay H, "Sudden hearing loss in a patient receiving piperacillin/tazobactam and daptomycin for diabetic foot infection", Scandinavian journal of infectious diseases, 2013 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on daptomycin (the active ingredients of Daptomycin) and Daptomycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.